Erratum: Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency (Oncology Letters (2020) 19 (3789-3798) DOI: 10.3892/ol.2020.11479)

Jinhuan Wang, Zhaoyi Miao, Yanan Jiang, Ping Zou, Weiming Li, Xiaoqiong Tang, Yangyang Lv, Donghui Xing, Shi Chen, Fengchun Yang, Mingjiang Xu, Zeng Cao, Haitao Wang, Zhigang Zhao

Research output: Contribution to journalComment/debatepeer-review

Abstract

Subsequently to the publication of the above article, the authors have realized that three of the four fluorescence-activated cell sorting (FACS) images in Fig. 2B were selected incorrectly. Furthermore, the pie charts shown in Fig. 3A were labelled incorrectly; essentially, the pie charts from left to right should have been labelled as 'Myeloid malignancy' and 'Normal', respectively). Corrected versions of Figs. 2 and 3 are shown on the next page. The authors would like to thank the Editor of Oncology Letters for allowing them the opportunity to publish this corrigendum, and apologize to the readership of the Journal for any inconvenience caused.

Original languageEnglish (US)
Article numbere11907
JournalOncology Letters
Volume20
Issue number4
DOIs
StatePublished - Oct 2020

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Erratum: Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency (Oncology Letters (2020) 19 (3789-3798) DOI: 10.3892/ol.2020.11479)'. Together they form a unique fingerprint.

Cite this